APA (7th ed.) Citation

MM, A., SM, A., NN, A., NS, A., & FF, A. (2025). Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase. Therapeutic innovation & regulatory science, 59(6), 1432. https://doi.org/10.1007/s43441-025-00826-7

Chicago Style (17th ed.) Citation

MM, AlRasheed, AlHawas SM, AlOrf NN, AlFadel NS, and AlHarbi FF. "Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase." Therapeutic Innovation & Regulatory Science 59, no. 6 (2025): 1432. https://doi.org/10.1007/s43441-025-00826-7.

MLA (9th ed.) Citation

MM, AlRasheed, et al. "Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase." Therapeutic Innovation & Regulatory Science, vol. 59, no. 6, 2025, p. 1432, https://doi.org/10.1007/s43441-025-00826-7.